The effect of amantadine on motor activity and catalepsy in rats.
D000547:Amantadine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002375:Catalepsy / Q000188:drug therapy*; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D002746:Chlorpromazine / Q000494:pharmacology; D003042:Cocaine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology; D013141:Spiro Compounds / Q000494:pharmacology; D013859:Thiocarbamates / Q000494:pharmacology
D002395:Catecholamines; D008781:Methyltyrosines; D013141:Spiro Compounds; D013859:Thiocarbamates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D000547:Amantadine; D003042:Cocaine; D009526:Nialamide; D003891:Desipramine; D002746:Chlorpromazine